IT1244543B - Uso topico della fosfomicina e dei suoi sali nella terapia delle infezioni vaginali e/o uretrali - Google Patents

Uso topico della fosfomicina e dei suoi sali nella terapia delle infezioni vaginali e/o uretrali

Info

Publication number
IT1244543B
IT1244543B ITMI910244A ITMI910244A IT1244543B IT 1244543 B IT1244543 B IT 1244543B IT MI910244 A ITMI910244 A IT MI910244A IT MI910244 A ITMI910244 A IT MI910244A IT 1244543 B IT1244543 B IT 1244543B
Authority
IT
Italy
Prior art keywords
phosphomycin
vaginal
treatment
salts
topical use
Prior art date
Application number
ITMI910244A
Other languages
English (en)
Inventor
Paolo Marfe
Schiena Michele Di
Original Assignee
La Fa Re Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by La Fa Re Srl filed Critical La Fa Re Srl
Priority to ITMI910244A priority Critical patent/IT1244543B/it
Publication of ITMI910244A0 publication Critical patent/ITMI910244A0/it
Priority to EP92101224A priority patent/EP0498243B1/en
Priority to DE69210635T priority patent/DE69210635D1/de
Publication of ITMI910244A1 publication Critical patent/ITMI910244A1/it
Application granted granted Critical
Publication of IT1244543B publication Critical patent/IT1244543B/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/655—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
    • C07F9/65502—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a three-membered ring
    • C07F9/65505—Phosphonic acids containing oxirane groups; esters thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/62—Quaternary ammonium compounds
    • C07C211/63—Quaternary ammonium compounds having quaternised nitrogen atoms bound to acyclic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Si descrive un nuovo uso della Fosfomicina di formula (FORMULA I) e dei suoi sali farmaceuticamente accettabili, quali il cetiltremetilammonio, per la preparazione di un medicamento per l'applicazione topica locale nel trattamento delle infezioni vaginali e/o uretrali.
ITMI910244A 1991-02-01 1991-02-01 Uso topico della fosfomicina e dei suoi sali nella terapia delle infezioni vaginali e/o uretrali IT1244543B (it)

Priority Applications (3)

Application Number Priority Date Filing Date Title
ITMI910244A IT1244543B (it) 1991-02-01 1991-02-01 Uso topico della fosfomicina e dei suoi sali nella terapia delle infezioni vaginali e/o uretrali
EP92101224A EP0498243B1 (en) 1991-02-01 1992-01-27 Fosfomycin cetyltrimethylammonium salt and composition containing it, for the topical treatment of vaginal and urethral infections
DE69210635T DE69210635D1 (de) 1991-02-01 1992-01-27 Fosfomycin-Cetyltrimethylammonium-Salz und diese enthaltende Zusammensetzung für die lokale Behandlung von Vagina- und Harnröhre-Infektionen

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI910244A IT1244543B (it) 1991-02-01 1991-02-01 Uso topico della fosfomicina e dei suoi sali nella terapia delle infezioni vaginali e/o uretrali

Publications (3)

Publication Number Publication Date
ITMI910244A0 ITMI910244A0 (it) 1991-02-01
ITMI910244A1 ITMI910244A1 (it) 1992-08-01
IT1244543B true IT1244543B (it) 1994-07-15

Family

ID=11358358

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI910244A IT1244543B (it) 1991-02-01 1991-02-01 Uso topico della fosfomicina e dei suoi sali nella terapia delle infezioni vaginali e/o uretrali

Country Status (3)

Country Link
EP (1) EP0498243B1 (it)
DE (1) DE69210635D1 (it)
IT (1) IT1244543B (it)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3856422B2 (ja) * 1999-01-05 2006-12-13 ニプロ株式会社 動物胚培養用培地
ITMI20021725A1 (it) 2002-08-01 2002-10-31 Zambon Spa Composizioni farmaceutiche ad attivita' antibiotica.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1161974B (it) * 1978-02-02 1987-03-18 Italchemi Spa Derivti dell acido cis.i 2 epossipropilfosfonico loro procedimento di preparazione e composizioni farmaceutiche che li contengono

Also Published As

Publication number Publication date
EP0498243B1 (en) 1996-05-15
EP0498243A2 (en) 1992-08-12
ITMI910244A0 (it) 1991-02-01
DE69210635D1 (de) 1996-06-20
ITMI910244A1 (it) 1992-08-01
EP0498243A3 (en) 1992-12-16

Similar Documents

Publication Publication Date Title
IT1253711B (it) Formulazioni farmaceutiche vaginali contenenti rifaximin e loro uso nel trattamento delle infezioni vaginali
RS41904A (en) Macrolides
TW336939B (en) Lipopeptide derivatives, a process for their preparation and their use
MX9702382A (es) Nuevos derivados de pirimidona con actividad antifungica.
TR199802060T2 (xx) Aminoisokinolinler ve aminopiridin t�revlerinin iltihap �nleyiciler olarak kullan�m�.
IT1254321B (it) Composizione farmaceutica per il trattamento e la prevenzione delle infiammazioni cutanee e della mucosa orale.
CA2411008A1 (en) Derivatives of 2,3,6,7,12,12a-hexahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione
IT1263004B (it) Impiego della l-carnitina e acil l-carnitine nel trattamento a lungo termine di pazienti diabetici non insulino-dipendenti.
IT1255802B (it) Derivati imidazolici ad attivita' a ii antagonista
ES2160602T3 (es) Derivados de quinolona y acridinona para el tratamiento de la incontinencia urinaria.
CA2200480A1 (en) New use of prostaglandins
TR199900661T2 (xx) Cilt enfeksiyonlar�n�n tedavisi amac�yla 1-hidroksi-2-piridonlar�n kullan�m�
IT1247509B (it) Composti di sintesi atti all'impiego nella terapia delle infezioni da rhinovirus
ES2124256T3 (es) Arilmorfolina, preparacion y uso.
DK1187611T3 (da) Oftalmiske histaminholdige sammensætninger og anvendelse deraf
IT1244543B (it) Uso topico della fosfomicina e dei suoi sali nella terapia delle infezioni vaginali e/o uretrali
IT1256623B (it) Antagonisti delle tachichinine, procedimento per la loro preparazione e loro impiego in formulazioni farmaceutiche
TR199900662T2 (xx) 1-Hidroksi-2-piridonlar�n seborik dermatit tedavisi amac�yla kullan�m�
KR950701612A (ko) 포타슘 채널 오프너 및 요실금 치료제로서의 알콜(alcohols as potassium channel openers and in treatment of urinary inconitnence)
PT986386E (pt) Uso de derivados heterociclicos aromaticos com azoto no tratamento topico de doencas dos tecidos epiteliais
NO980058L (no) Opthalmiske preparater
CA2159889A1 (en) Surfactant Composition Containing a Sodium Polyoxyethylene Alkyl Ether Sulfate Surfactant and a Sulphosuccinate Surfactant
ATE330958T1 (de) Pyrazino 1'2':1,6öpyrido 3,4-böindolderivate
IT1255461B (it) Eteri di imidazoli ad attivita' a ii antagonista
ES2007419A6 (es) Un procedimiento para la preparacion de un glicosido de antraciclina.

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970225